CYPHERPUNK TECHNOLOGIES INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
CYPHERPUNK TECHNOLOGIES INC. (CYPH) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 1.00 million shares for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-16.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-03-16
- CYPHERPUNK TECHNOLOGIES INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-06-30 was 0.00 shares, a 100.00% decline year-over-year.
- CYPHERPUNK TECHNOLOGIES INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-03-31 was 0.00 shares, a 100.00% decline year-over-year.
- CYPHERPUNK TECHNOLOGIES INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2024-12-31 was 1.73M shares, a 2210.00% increase year-over-year.
- CYPHERPUNK TECHNOLOGIES INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2024-09-30 was 90.00K shares, a 93.84% decline year-over-year.
- CYPHERPUNK TECHNOLOGIES INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 1.00M shares, a 71.10% decline from fiscal 2024.
- CYPHERPUNK TECHNOLOGIES INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 3.46M shares, a 44.56% increase from fiscal 2023.
- CYPHERPUNK TECHNOLOGIES INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 2.39M shares, a 494.67% increase from fiscal 2022.
- CYPHERPUNK TECHNOLOGIES INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 402.49K shares, a 83.79% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-31 | 1.00M shares 10-K · filed 2026-03-16 | ||||
| 2025-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | 0.00 shares 10-Q · filed 2025-08-14 | 1.73M shares derived: sum of 3 quarters · filed 2026-03-16 | 1.82M shares derived: sum of 4 quarters · filed 2026-03-16 | |
| 2025-03-31 | 0.00 shares 10-Q · filed 2025-05-13 | 1.73M shares derived: sum of 2 quarters · filed 2026-03-16 | 1.82M shares derived: sum of 3 quarters · filed 2026-03-16 | 1.83M shares derived: sum of 4 quarters · filed 2026-03-16 | |
| 2024-12-31 | 1.73M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | 1.82M shares derived: sum of 2 quarters · filed 2026-03-16 | 1.83M shares derived: sum of 3 quarters · filed 2026-03-16 | 3.46M shares 10-K · filed 2026-03-16 | |
| 2024-09-30 | 90.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | 95.00K shares derived: sum of 2 quarters · filed 2024-11-13 | 1.73M shares 10-Q · filed 2024-11-13 | 1.80M shares derived: sum of 4 quarters · filed 2025-03-26 | |
| 2024-06-30 | 5.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | 1.64M shares 10-Q · filed 2024-08-12 | 1.71M shares derived: sum of 3 quarters · filed 2025-03-26 | 3.17M shares derived: sum of 4 quarters · filed 2025-03-26 | |
| 2024-03-31 | 1.63M shares 10-Q · filed 2024-05-13 | 1.71M shares derived: sum of 2 quarters · filed 2025-03-26 | 3.17M shares derived: sum of 3 quarters · filed 2025-03-26 | -4.21M shares derived: sum of 4 quarters · filed 2025-03-26 | |
| 2023-12-31 | 75.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26 | 1.53M shares derived: sum of 2 quarters · filed 2025-03-26 | -5.84M shares derived: sum of 3 quarters · filed 2025-03-26 | 2.39M shares 10-K · filed 2025-03-26 | |
| 2023-09-30 | 1.46M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -5.92M shares derived: sum of 2 quarters · filed 2023-11-13 | 2.32M shares 10-Q · filed 2023-11-13 | -1.18M shares derived: sum of 4 quarters · filed 2024-03-18 | |
| 2023-06-30 | -7.38M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | 858.50K shares 10-Q · filed 2023-08-14 | -2.64M shares derived: sum of 3 quarters · filed 2024-03-18 | 515.99K shares derived: sum of 4 quarters · filed 2024-03-18 | |
| 2023-03-31 | 8.23M shares 10-Q · filed 2023-05-15 | 4.74M shares derived: sum of 2 quarters · filed 2024-03-18 | 7.89M shares derived: sum of 3 quarters · filed 2024-03-18 | 7.99M shares derived: sum of 4 quarters · filed 2024-03-18 | |
| 2022-12-31 | -3.50M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-18 | -342.51K shares derived: sum of 2 quarters · filed 2024-03-18 | -247.51K shares derived: sum of 3 quarters · filed 2024-03-18 | 402.49K shares 10-K · filed 2024-03-18 | 4.02M shares 10-K · filed 2023-03-24 |
| 2022-09-30 | 3.15M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | 3.25M shares derived: sum of 2 quarters · filed 2022-11-14 | 3.90M shares 10-Q · filed 2022-11-14 | 3.94M shares derived: sum of 4 quarters · filed 2023-03-24 | |
| 2022-06-30 | 95.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | 745.00K shares 10-Q · filed 2022-08-12 | 790.00K shares derived: sum of 3 quarters · filed 2023-03-24 | 891.15K shares derived: sum of 4 quarters · filed 2023-03-24 | |
| 2022-03-31 | 650.00K shares 10-Q · filed 2022-05-13 | 695.00K shares derived: sum of 2 quarters · filed 2023-03-24 | 796.15K shares derived: sum of 3 quarters · filed 2023-03-24 | 1.58M shares derived: sum of 4 quarters · filed 2023-03-24 | |
| 2021-12-31 | 45.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-24 | 146.15K shares derived: sum of 2 quarters · filed 2023-03-24 | 926.15K shares derived: sum of 3 quarters · filed 2023-03-24 | 2.48M shares 10-K · filed 2023-03-24 | |
| 2021-09-30 | 101.15K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | 881.15K shares derived: sum of 2 quarters · filed 2021-11-12 | 2.44M shares 10-Q · filed 2021-11-12 | 2.55M shares derived: sum of 4 quarters · filed 2022-03-11 | |
| 2021-06-30 | 780.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | 2.34M shares 10-Q · filed 2021-08-13 | 2.45M shares derived: sum of 3 quarters · filed 2022-03-11 | 3.25M shares derived: sum of 4 quarters · filed 2022-03-11 | |
| 2021-03-31 | 1.56M shares 10-Q · filed 2021-05-14 | 1.67M shares derived: sum of 2 quarters · filed 2022-03-11 | 2.47M shares derived: sum of 3 quarters · filed 2022-03-11 | 2.95M shares derived: sum of 4 quarters · filed 2022-03-11 | |
| 2020-12-31 | 115.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | 912.50K shares derived: sum of 2 quarters · filed 2022-03-11 | 1.40M shares derived: sum of 3 quarters · filed 2022-03-11 | 2.66M shares 10-K · filed 2022-03-11 | |
| 2020-09-30 | 797.50K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | 1.28M shares derived: sum of 2 quarters · filed 2020-11-12 | 2.55M shares 10-Q · filed 2020-11-12 | 2.55M shares derived: sum of 4 quarters · filed 2021-03-12 | |
| 2020-06-30 | 485.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | 1.75M shares 10-Q · filed 2020-08-13 | 1.75M shares derived: sum of 3 quarters · filed 2021-03-12 | 1.76M shares derived: sum of 4 quarters · filed 2021-03-12 | |
| 2020-03-31 | 1.26M shares 10-Q · filed 2020-05-14 | 1.27M shares derived: sum of 2 quarters · filed 2021-03-12 | 1.28M shares derived: sum of 3 quarters · filed 2021-03-12 | 2.53M shares derived: sum of 4 quarters · filed 2021-03-12 | |
| 2019-12-31 | 5.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | 12.50K shares derived: sum of 2 quarters · filed 2021-03-12 | 1.27M shares derived: sum of 3 quarters · filed 2021-03-12 | 1.48M shares 10-K · filed 2021-03-12 | |
| 2019-09-30 | 7.50K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | 1.26M shares derived: sum of 2 quarters · filed 2019-11-14 | 1.48M shares 10-Q · filed 2019-11-14 | 1.63M shares derived: sum of 4 quarters · filed 2020-03-16 | |
| 2019-06-30 | 1.25M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | 1.47M shares 10-Q · filed 2019-08-09 | 1.62M shares derived: sum of 3 quarters · filed 2020-03-16 | 1.64M shares derived: sum of 4 quarters · filed 2020-03-16 | |
| 2019-03-31 | 214.47K shares 10-Q · filed 2019-05-15 | 368.73K shares derived: sum of 2 quarters · filed 2020-03-16 | 381.23K shares derived: sum of 3 quarters · filed 2020-03-16 | ||
| 2018-12-31 | 154.25K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | 166.75K shares derived: sum of 2 quarters · filed 2020-03-16 | 599.05K shares 10-K · filed 2020-03-16 | ||
| 2018-09-30 | 12.50K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | 444.80K shares 10-Q · filed 2018-11-09 | |||
| 2018-06-30 | 432.30K shares 10-Q · filed 2018-08-08 | ||||
| 2017-12-31 | 395.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | 395.00K shares derived: sum of 2 quarters · filed 2019-04-01 | 395.00K shares derived: sum of 3 quarters · filed 2019-04-01 | 2.22M shares 10-K · filed 2019-04-01 | |
| 2017-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13 | 0.00 shares derived: sum of 2 quarters · filed 2017-11-13 | 1.83M shares 10-Q · filed 2017-11-13 | ||
| 2017-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-11 | 1.83M shares 10-Q · filed 2017-08-11 | |||
| 2017-03-31 | 1.83M shares 10-Q · filed 2017-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |